Thomson Reuters Corporation (TSX:TRI)

Aerovate Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	664	1,968	1,298	1,069	778	1,787
Short-Term Investments	63	35	66	204	108	612
Cash & Short-Term Investments	727	2,003	1,364	1,273	886	2,399
Cash Growth	-57.21%	46.85%	7.15%	43.68%	-63.07%	76.66%
Accounts Receivable	1,088	1,058	1,049	1,040	1,038	1,122
Other Receivables	-	96	145	97	87	94
Receivables	1,088	1,154	1,194	1,137	1,125	1,216
Inventory	-	21	20	29	28	26
Prepaid Expenses	441	150	161	159	170	126
Other Current Assets	-	162	182	213	244	208
Total Current Assets	2,256	3,490	2,921	2,811	2,453	3,975
Property, Plant & Equipment	375	386	447	414	502	545
Long-Term Investments	284	269	2,030	6,684	6,736	1,234
Goodwill	7,835	7,262	6,719	5,869	5,940	5,976
Other Intangible Assets	4,770	4,587	4,401	4,154	4,153	4,257
Long-Term Deferred Tax Assets	1,367	1,376	1,104	1,118	1,139	1,204
Long-Term Deferred Charges	-	98	108	121	127	105
Other Long-Term Assets	1,079	969	954	540	1,099	585
Total Assets	17,966	18,437	18,684	21,711	22,149	17,881
Accounts Payable	-	176	181	237	227	217
Accrued Expenses	-	819	843	884	992	807
Short-Term Debt	499	-	130	1,048	-	-
Current Portion of Long-Term Debt	-	994	242	599	-	-
Current Portion of Leases	-	58	56	56	64	83
Current Income Taxes Payable	187	197	248	324	169	251
Current Unearned Revenue	1,164	1,062	992	886	874	866
Other Current Liabilities	1,004	130	541	857	255	428
Total Current Liabilities	2,854	3,436	3,233	4,891	2,581	2,652
Long-Term Debt	1,342	1,847	2,905	3,114	3,786	3,772
Long-Term Leases	-	198	209	179	197	223
Long-Term Deferred Tax Liabilities	299	241	553	897	1,005	394
Other Long-Term Liabilities	855	186	185	219	240	262
Total Liabilities	5,350	6,431	7,620	9,826	8,315	7,901
Common Stock	3,578	1,957	1,791	3,754	3,703	3,609
Additional Paid-In Capital	-	1,431	1,504	1,534	1,683	1,739
Retained Earnings	9,933	9,699	8,680	7,642	9,149	5,211
Comprehensive Income & Other	-895	-1,191	-1,021	-1,155	-811	-689
Total Common Equity	12,616	11,896	10,954	11,775	13,724	9,870
Shareholders' Equity	12,616	12,006	11,064	11,885	13,834	9,980
Total Liabilities & Equity	17,966	18,437	18,684	21,711	22,149	17,881
Total Debt	1,841	3,097	3,542	4,996	4,047	4,078
Net Cash (Debt)	-1,114	-1,094	-2,178	-3,723	-3,161	-1,679
Net Cash Per Share	-2.47	-2.42	-4.69	-7.96	-6.63	-3.50
Filing Date Shares Outstanding	450.67	450.1	451.36	454.84	468.76	477.02
Total Common Shares Outstanding	450.67	450.01	452.96	458.9	468.57	479.2
Working Capital	-598	54	-312	-2,080	-128	1,323
Book Value Per Share	27.99	26.43	24.18	25.66	29.29	20.60
Tangible Book Value	11	47	-166	1,752	3,631	-363
Tangible Book Value Per Share	0.02	0.10	-0.37	3.82	7.75	-0.76
Land	-	620	801	838	923	914
Machinery	-	412	495	532	571	1,088

Source: S&P Global Market Intelligence. Standard template. Financial Sources.